Prostate cancer is the single most common cancer of non-skin cancer in men in the United States. In the year 2021, an estimated 248,530 men will be diagnosed, and some 34,130 will die of the disease. The cornerstones of diagnosis remain the digital rectal examination and PSA (Prostate Specific Antigen). Newer measurements of PSA, including %Free PSA, will allow more informed decision making by your urologist regarding prostate cancer diagnosis. Transrectal ultrasound and prostate biopsy are the procedures performed to diagnose prostate cancer.
The American Urological Association recommends an annual digital rectal exam and PSA for all men 55 years of age and older who are in good health. High risk patients including patients with a family history of prostate cancer may consider having an annual PSA and a rectal exam earlier than age 55. Prostate cancer exacts a particularly high toll on African-American men; mortality rates in African-American men are more that twice as high as rates in white men.
Central Arizona Urologists offer all treatment options for prostate cancer including nerve sparing radical prostatectomy , hormonal therapy, and cryotherapy. We also participate with our radiation oncology colleagues in placing radioactive fiducial markers to assist in IMRT and Cyberknife therapy. Prostate cancer treatments should be selected based on many criteria, including pathology information, patient age, and medical history.
Informative Prostate Cancer Links:American Cancer SocietyNational Cancer Institute(CancerNet)Varian- EndoCare CryotherapyProstate Cancer Support Group (Us Too)Prostate Cancer ArticlesVIDEO- Prostate Cryotherapy
Central Arizona Urologists offers prostate cancer treatments in Phoenix and all surrounding areas including Scottsdale, Tucson, Glendale, Mesa, Tempe, and Gilbert.
